THC Tenet Healthcare Corp.

Fundamentals / CIK 0000070318 / USD

Tenet Healthcare Corp. reported $22.15B in revenue and net income of $2.90B for the trailing twelve months ended September 30, 2026 (up 6.5% year over year), with a 24.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open THC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$21.08B$10.54B$0-$2.47BFY 2016 Revenue: $19.62BFY 2016 Net Income: -$192.0M2016FY 2017 Revenue: $19.18BFY 2017 Net Income: -$704.0M2017FY 2018 Revenue: $18.31BFY 2018 Net Income: $104.0M2018FY 2019 Revenue: $18.48BFY 2019 Net Income: -$215.0M2019FY 2020 Revenue: $17.64BFY 2020 Net Income: $399.0M2020FY 2021 Revenue: $19.48BFY 2021 Net Income: $914.0M2021FY 2022 Revenue: $19.17BFY 2022 Net Income: $411.0M2022FY 2023 Revenue: $20.56BFY 2023 Net Income: $611.0M2023FY 2024 Revenue: $20.68BFY 2024 Net Income: $3.20B2024FY 2025 Revenue: $21.31BFY 2025 Net Income: $1.41B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $21.31B $20.68B $20.56B $19.17B $19.48B $17.64B $18.48B $18.31B $19.18B $19.62B
Operating Income $3.51B $5.96B $2.51B $2.33B $2.87B $1.99B $1.54B $1.64B $1.11B $1.25B
EBITDA $4.37B $6.77B $3.38B $3.17B $3.73B $2.85B $2.39B $2.44B $1.98B $2.10B
Interest Expense $821.0M $826.0M $901.0M $890.0M $923.0M $1.00B $985.0M $1.00B $1.03B $979.0M
Income Before Tax $2.80B $5.25B $1.62B $1.34B $1.89B $671.0M $320.0M $629.0M -$101.0M $248.0M
Income Tax Expense $433.0M $1.18B $306.0M $344.0M $411.0M -$97.00M $160.0M $173.0M $219.0M $67.00M
Net Income $1.41B $3.20B $611.0M $411.0M $914.0M $399.0M -$215.0M $104.0M -$704.0M -$192.0M
Basic EPS $15.61 $33.02 $6.01 $3.84 $8.55 $3.80 -$2.08 $1.02 -$7.00 -$1.93
Diluted EPS $15.49 $32.70 $5.71 $3.79 $8.42 $3.75 -$2.08 $1.00 -$7.00 -$1.93
Basic Shares Outstanding 90.2M 96.9M 101.6M 106.9M 106.8M 105.0M 103.4M 102.1M 100.6M 99.3M
Diluted Shares Outstanding 90.8M 97.9M 104.8M 110.5M 108.6M 106.3M 103.4M 103.9M 100.6M 99.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $5.63B $5.63B $5.37B $5.53B $5.29B $5.27B $5.22B $5.07B
Operating Income $1.75B $1.50B $1.30B $853.0M $889.0M $823.0M $943.0M $821.0M
EBITDA $1.97B $1.72B $1.52B $1.08B $1.11B $1.03B $1.15B $1.01B
Interest Expense $203.0M $204.0M $205.0M $205.0M $206.0M $206.0M $204.0M $203.0M
Income Before Tax -- $1.34B $1.13B $681.0M $712.0M $642.0M $765.0M $655.0M
Income Tax Expense $360.0M $295.0M $226.0M $37.00M $133.0M $120.0M $143.0M $83.00M
Net Income $1.00B $826.0M $702.0M $371.0M $342.0M $288.0M $406.0M $318.0M
Basic EPS $12.48 $9.89 $8.09 -- $3.89 $3.16 $4.31 --
Diluted EPS $12.41 $9.84 $8.01 -- $3.86 $3.14 $4.27 --
Basic Shares Outstanding 80.1M 83.5M 86.8M -- 88.0M 91.1M 94.2M --
Diluted Shares Outstanding 80.6M 84.0M 87.6M -- 88.6M 91.8M 95.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $2.88B $3.02B $1.23B $858.0M $2.36B $2.45B $262.0M $411.0M $611.0M $716.0M
Cash & Short-Term Investments $2.88B $3.02B $1.23B $858.0M $2.36B $2.45B $262.0M $411.0M $611.0M $716.0M
Accounts Receivable, Net $2.56B $2.54B $2.91B $2.94B $2.77B $2.69B $2.74B $2.60B $2.62B $2.90B
Inventory $348.0M $346.0M $411.0M $405.0M $384.0M $368.0M $310.0M $305.0M $289.0M $326.0M
Other Current Assets $1.99B $1.76B $1.84B $1.77B $1.56B $1.50B $1.37B $1.20B $1.03B $1.28B
Total Current Assets $7.85B $7.68B $7.17B $5.98B $7.08B $7.15B $5.08B $4.64B $5.57B $5.26B
Property, Plant & Equipment, Net $6.32B $6.05B $6.24B $6.46B $6.43B $6.69B $6.88B $6.99B $7.03B $8.05B
Goodwill $11.20B $10.69B $10.31B $10.12B $9.26B $8.81B $7.25B $7.28B $7.02B $7.42B
Intangible Assets $1.35B $1.40B $1.37B $1.42B $1.50B $1.60B $1.60B $1.73B $1.77B $1.84B
Long-Term Investments $1.44B $1.53B $1.56B $1.63B $1.81B $1.03B $980.0M $996.0M $1.01B $984.0M
Total Non-Current Assets $21.83B $21.25B $21.14B $21.18B $20.50B $19.96B $18.28B $17.79B $17.81B $19.44B
Total Assets $29.68B $28.94B $28.31B $27.16B $27.58B $27.11B $23.36B $22.43B $23.39B $24.70B
Accounts Payable $1.36B $1.29B $1.41B $1.50B $1.30B $1.21B $1.20B $1.21B $1.18B $1.33B
Deferred Revenue (Current) -- $0 $0 $110.0M $959.0M $659.0M $61.00M -- -- --
Other Current Liabilities $1.81B $1.61B $1.76B $1.58B $1.36B $1.33B $1.27B $1.13B $1.23B $1.24B
Total Current Liabilities $4.46B $4.31B $4.76B $4.48B $5.11B $4.85B $4.21B $3.86B $4.33B $4.03B
Long-Term Debt $13.09B $13.08B $14.88B $14.93B $15.51B $15.57B $14.58B $14.64B $14.79B $15.06B
Deferred Revenue (Non-Current) -- -- -- $13.00M $15.00M $918.0M $18.00M -- -- --
Other Non-Current Liabilities $1.71B $1.57B $1.71B $1.80B $1.44B $1.62B $1.40B $578.0M $631.0M $610.0M
Total Non-Current Liabilities $16.24B $16.08B $18.04B $18.07B $18.21B $19.37B $17.22B $16.45B $16.65B $17.19B
Total Liabilities $20.70B $20.39B $22.80B $22.55B $23.32B $24.22B $21.42B $20.30B $20.98B $21.23B
Total Debt (incl. Leases) $14.52B $14.42B $16.33B $16.46B $16.92B $17.08B $15.95B $15.01B $15.17B $15.49B
Common Stock $8.00M $8.00M $8.00M $8.00M $8.00M $7.00M $7.00M $7.00M $7.00M $7.00M
Retained Earnings $4.42B $3.01B -$192.0M -$803.0M -$1.21B -$2.13B -$2.51B -$2.24B -$2.39B -$1.74B
Accumulated Other Comp. Income -$181.0M -$180.0M -$181.0M -$181.0M -$233.0M -$281.0M -$257.0M -$223.0M -$204.0M -$258.0M
Total Stockholders' Equity $4.22B $4.17B $1.61B $1.14B $1.03B $28.00M -$417.0M -$119.0M -$147.0M $417.0M
Total Equity $6.02B $5.82B $3.12B $2.46B $2.05B $937.0M $437.0M $624.0M $483.0M $1.08B

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.67B $2.17B $2.97B $2.88B $2.98B $2.62B $3.00B $3.02B
Cash & Short-Term Investments $2.67B $2.17B $2.97B $2.88B $2.98B $2.62B $3.00B $3.02B
Accounts Receivable, Net $2.60B $2.61B $2.60B $2.56B $2.52B $2.53B $2.62B $2.54B
Inventory $340.0M $338.0M $343.0M $348.0M $346.0M $338.0M $344.0M $346.0M
Other Current Assets $2.76B $2.65B $2.38B $1.99B $1.89B $1.78B $1.93B $1.76B
Total Current Assets $8.43B $7.83B $8.36B $7.85B $7.81B $7.30B $7.91B $7.68B
Property, Plant & Equipment, Net $6.29B $6.26B $6.25B $6.32B $6.09B $6.02B $5.99B $6.05B
Goodwill $11.64B $11.44B $11.39B $11.20B $11.16B $10.94B $10.79B $10.69B
Intangible Assets $1.23B $1.28B $1.32B $1.35B $1.35B $1.37B $1.40B $1.40B
Long-Term Investments -- -- -- $1.44B -- -- -- $1.53B
Total Non-Current Assets $23.16B $22.85B $22.85B $21.83B $21.61B $21.40B $21.32B $21.25B
Total Assets $31.59B $30.68B $31.20B $29.68B $29.42B $28.70B $29.24B $28.94B
Accounts Payable $1.39B $1.37B $1.34B $1.36B $1.36B $1.36B $1.33B $1.29B
Deferred Revenue (Current) -- -- -- -- -- -- -- $0
Other Current Liabilities $2.34B $2.70B $3.08B $1.81B $1.69B $1.57B $1.65B $1.61B
Total Current Liabilities $5.32B $5.57B $6.15B $4.46B $4.56B $4.27B $4.45B $4.31B
Long-Term Debt $13.08B $13.09B $13.13B $13.09B $13.10B $13.09B $13.08B $13.08B
Other Non-Current Liabilities $1.85B $1.78B $1.69B $1.71B $1.60B $1.64B $1.65B $1.57B
Total Non-Current Liabilities $16.68B $16.41B $16.20B $16.24B $16.16B $16.13B $16.13B $16.08B
Total Liabilities $22.00B $21.98B $22.35B $20.70B $20.72B $20.40B $20.58B $20.39B
Total Debt (incl. Leases) $13.24B $13.25B $13.21B $14.52B $13.19B $13.18B $13.17B $14.42B
Common Stock $8.00M $8.00M $8.00M $8.00M $8.00M $8.00M $8.00M $8.00M
Retained Earnings $6.94B $5.94B $5.12B $4.42B $4.04B $3.70B $3.41B $3.01B
Accumulated Other Comp. Income -$178.0M -$177.0M -$179.0M -$181.0M -$174.0M -$177.0M -$178.0M -$180.0M
Total Stockholders' Equity $5.44B $4.66B $4.81B $4.22B $4.01B $3.75B $4.18B $4.17B
Total Equity $7.42B $6.56B $6.71B $6.02B $5.78B $5.48B $5.88B $5.82B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $2.37B $4.06B $1.31B $1.00B $1.48B $768.0M $171.0M $459.0M -$320.0M $176.0M
Depreciation & Amortization $863.0M $818.0M $870.0M $841.0M $855.0M $857.0M $850.0M $802.0M $870.0M $850.0M
Stock-Based Compensation $104.0M $67.00M $66.00M $56.00M $56.00M $44.00M $42.00M $46.00M $59.00M $68.00M
Change in Receivables $20.00M $245.0M -$29.00M -$140.0M -$197.0M $195.0M -$247.0M -$134.0M -$1.45B -$1.60B
Operating Cash Flow $3.54B $2.05B $2.37B $1.08B $1.57B $3.41B $1.23B $1.05B $1.20B $558.0M
Capital Expenditure -$1.01B -$931.0M -$751.0M -$762.0M -$658.0M -$540.0M -$670.0M -$617.0M -$707.0M -$875.0M
Free Cash Flow $2.53B $1.12B $1.62B $321.0M $910.0M $2.87B $563.0M $432.0M $493.0M -$317.0M
Acquisitions, Net -$308.0M -$571.0M -$224.0M -$234.0M -$1.22B -$1.18B -$25.00M -$113.0M -$50.00M -$117.0M
Purchases of Investments -$90.00M -$94.00M -$104.0M -$92.00M -$108.0M -$44.00M -$62.00M -$148.0M -$81.00M --
Sales & Maturities of Investments -- -- $50.00M $76.00M $31.00M -- -- -- -- --
Investing Cash Flow -$1.27B $3.43B -$969.0M -$808.0M -$714.0M -$1.61B -$619.0M -$115.0M $21.00M -$430.0M
Share Repurchases -$1.39B -$672.0M -$200.0M -$250.0M $0 $0 -- -- $0 $0
Financing Cash Flow -$2.40B -$3.69B -$1.03B -$1.78B -$936.0M $385.0M -$763.0M -$1.13B -$1.33B $232.0M
Net Change in Cash -$136.0M $1.79B $370.0M -$1.51B -$82.00M $2.18B -$149.0M -$200.0M -$105.0M $360.0M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $1.22B $1.04B $906.0M $644.0M $579.0M $522.0M $622.0M $572.0M
Depreciation & Amortization $217.0M $215.0M $229.0M $231.0M $218.0M $208.0M $206.0M $193.0M
Stock-Based Compensation $35.00M $44.00M $25.00M $25.00M $38.00M $20.00M $21.00M $15.00M
Change in Receivables $22.00M -$5.00M -$28.00M -$48.00M $28.00M $109.0M -$69.00M $62.00M
Operating Cash Flow $1.28B $585.0M $1.64B $731.0M $1.06B $936.0M $815.0M -$331.0M
Capital Expenditure -$198.0M -$168.0M -$180.0M -$364.0M -$280.0M -$193.0M -$173.0M -$330.0M
Free Cash Flow $1.08B $417.0M $1.46B $367.0M $778.0M $743.0M $642.0M -$661.0M
Acquisitions, Net -$71.00M -$9.00M -$121.0M -$42.00M -$119.0M -$120.0M -$27.00M -$47.00M
Purchases of Investments -$45.00M -$51.00M -$26.00M -$21.00M -$31.00M -$21.00M -$17.00M -$48.00M
Investing Cash Flow -$298.0M -$203.0M -$317.0M -$389.0M -$385.0M -$314.0M -$187.0M -$372.0M
Share Repurchases -$255.0M -$1.04B -$318.0M -$198.0M -$93.00M -$747.0M -$348.0M $0
Financing Cash Flow -$479.0M -$1.18B -$1.24B -$434.0M -$323.0M -$996.0M -$648.0M -$372.0M
Net Change in Cash $504.0M -$797.0M $84.00M -$92.00M $350.0M -$374.0M -$20.00M -$1.07B

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 16.5% 28.8% 12.2% 12.2% 14.7% 11.3% 8.3% 8.9% 5.8% 6.4%
Net Profit Margin 6.6% 15.5% 3.0% 2.1% 4.7% 2.3% -1.2% 0.6% -3.7% -1.0%
Return on Equity (ROE) 33.3% 76.7% 38.0% 36.0% 88.9% 1425.0% -- -- -- -46.0%
Return on Assets (ROA) 4.7% 11.1% 2.2% 1.5% 3.3% 1.5% -0.9% 0.5% -3.0% -0.8%
Current Ratio 1.76x 1.78x 1.51x 1.34x 1.38x 1.47x 1.21x 1.20x 1.29x 1.30x
Quick Ratio 1.68x 1.70x 1.42x 1.25x 1.31x 1.40x 1.13x 1.12x 1.22x 1.22x
Debt to Equity 3.44x 3.46x 10.16x 14.42x 16.46x 610.07x -- -- -- 37.15x
Revenue Growth (YoY) +3.1% +0.5% +7.2% -1.6% +10.5% -4.5% +0.9% -4.5% -2.3% --
Operating Income Growth (YoY) -41.1% +137.3% +7.6% -18.7% +44.3% +29.4% -6.1% +47.1% -10.7% +15.8%
Net Income Growth (YoY) -56.0% +423.7% +48.7% -55.0% +129.1% -- -306.7% -- -- --
EPS Growth (YoY) -52.7% +449.4% +56.5% -55.1% +125.0% -- -303.9% -- -- --
Operating Cash Flow Growth (YoY) +72.9% -13.8% +119.2% -30.9% -54.0% +176.3% +17.5% -12.6% +115.1% -45.6%
Free Cash Flow Growth (YoY) +126.7% -31.2% +405.6% -64.7% -68.3% +409.2% +30.3% -12.4% -- -272.3%
5Y Revenue / Share Growth +40.7% +19.4% +12.8% -6.0% -7.7% -- -- -- -- --
5Y Net Income / Share Growth +310.8% -- +490.2% -- -- -- -1794.7% -- -617.2% -490.6%
10Y Net Income / Share Growth -- +26813.5% -- +184.1% +1628.5% -58.9% -237.9% +385.2% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 24.4% 20.8% 18.0% 16.5% 16.7% 17.8% 17.6% 28.8%
Net Profit Margin 13.1% 10.3% 7.9% 6.6% 6.5% 7.2% 7.1% 15.5%
Return on Equity (ROE) 53.3% 48.1% 35.4% 33.3% 33.7% 39.6% 34.8% 76.7%
Return on Assets (ROA) 9.2% 7.3% 5.5% 4.7% 4.6% 5.2% 5.0% 11.1%
Current Ratio 1.58x 1.41x 1.36x 1.76x 1.71x 1.71x 1.78x 1.78x
Quick Ratio 1.52x 1.35x 1.30x 1.68x 1.64x 1.63x 1.70x 1.70x
Debt to Equity 2.43x 2.84x 2.74x 3.44x 3.29x 3.51x 3.15x 3.46x
Revenue Growth (YoY) +6.5% +6.8% +2.8% +8.9% +3.2% +3.2% -2.7% -6.0%
Operating Income Growth (YoY) +96.9% +82.4% +37.4% +3.9% -18.4% +8.1% -71.3% +11.7%
Net Income Growth (YoY) +192.4% +186.8% +72.9% +16.7% -27.5% +11.2% -81.1% +30.3%
EPS Growth (YoY) +220.8% +213.0% +87.7% -- -21.1% +18.8% -80.0% --
Operating Cash Flow Growth (YoY) +21.1% -37.5% +101.3% -- +1.2% +25.3% +39.1% -140.2%
Free Cash Flow Growth (YoY) +39.2% -43.9% +127.6% -- -6.2% +23.4% +85.5% -207.3%
Source: SEC EDGAR CompanyFacts (CIK 0000070318) · from December 31, 2008 Data through September 30, 2026 · synced Nov 20, 2026, 05:06 UTC · Open in terminal